Provided by Tiger Trade Technology Pte. Ltd.

ZYMEWORKS INC (US)

23.93
+0.61002.62%
Volume:263.17K
Turnover:6.31M
Market Cap:1.76B
PE:-22.16
High:24.19
Open:24.12
Low:23.70
Close:23.32
52wk High:28.49
52wk Low:9.03
Shares:73.75M
Float Shares:38.30M
Volume Ratio:0.67
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0800
EPS(LYR):-1.0800
ROE:-26.72%
ROA:-14.29%
PB:6.57
PE(LYR):-22.16

Loading ...

Earnings Flash (ZYME) Zymeworks Posts Q4 Net Loss $0.55 a Share, vs. FactSet Est of $0.46 Loss

MT Newswires Live
·
Mar 02

Canada's Zymeworks 2025 revenue rises 39%

Reuters
·
Mar 02

Zymeworks Q4 2025 EPS $(0.55) Misses $(0.42) Estimate, Sales $2.515M Miss $13.576M Estimate

Benzinga
·
Mar 02

Zymeworks and Royalty Pharma Enter Into $250 Million Royalty-Backed Note Financing

THOMSON REUTERS
·
Mar 02

Zymeworks Inc - Co to Retain 70% of Ziihera Royalties

THOMSON REUTERS
·
Mar 02

Zymeworks Secures $250 Million Royalty-Backed Note Financing From Royalty Pharma

Reuters
·
Mar 02

Zymeworks FY 2025 revenue rises 39% to USD 106.0 million

Reuters
·
Mar 02

Zymeworks Q4 Basic EPS USD -0.55

THOMSON REUTERS
·
Mar 02

Zymeworks Inc expected to post a loss of 42 cents a share - Earnings Preview

Reuters
·
Feb 27

Citi Reaffirms Their Buy Rating on Zymeworks (ZYME)

TIPRANKS
·
Feb 20

Zymeworks Inc. to Report Financial Results and Host Conference Call

Reuters
·
Feb 12

Zymeworks Inc. Files Initial Statement of Beneficial Ownership for SVP & Chief Medical Officer Sabeen Mekan

Reuters
·
Feb 03

Zymeworks Inc. Joins Leerink Global Healthcare Conference for Fireside Chat

Reuters
·
Jan 27

Assessing Zymeworks (ZYME) Valuation After Major Leadership And Board Reshuffle

Simply Wall St.
·
Jan 27

Zymeworks Inc. unveils strategy focused on growing royalty portfolio and advancing novel medicines for difficult-to-treat diseases

Reuters
·
Jan 21

Zymeworks Inc. Files Initial Beneficial Ownership Statement for Mark Hollywood, EVP & Chief Operating Officer

Reuters
·
Jan 14

Zymeworks Inc. Files Initial Statement of Beneficial Ownership for Director Brian N. Cherry

Reuters
·
Jan 14

BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners

Reuters
·
Jan 12

Zymeworks Chief Finance, Medical, Scientific Officers Leaving in Executive Reorg

Dow Jones
·
Jan 12

Zymeworks Inc. unveils pipeline progress and partnership milestones in latest corporate presentation

Reuters
·
Jan 12